Clinical trial

A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants

NCT05841238

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-04-26

PhasePHASE1

Study timeline

Study start (actual)2023-04-26Date precision: day

Registry last updated2026-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthyunresolved

Obeseunresolved

Interventions

LY3502970DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

DallasTexas, United States1 MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05841238 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.